Colofac (Mebeverine) Guide For Canadian Patients

Basic Colofac Information

• INN (International Nonproprietary Name): Mebeverine
• Brand Names Available In Canada (English): not specified
• ATC Code: A03AA04 — Drugs for functional gastrointestinal disorders, specifically synthetic anticholinergics, esters with tertiary amino group
• Forms & Dosages: Standard tablets 135 mg (1 tablet three times daily); Prolonged‑release capsules 200 mg (1 capsule twice daily); Oral liquid equivalents for swallowing difficulties
• Manufacturers In Canada (English): not specified
• Registration Status In Canada (English): not specified
• OTC / Rx Classification: OTC in some EU/UK pharmacies for small packs; prescription only in many other countries (including Australia); local Canadian classification not specified — check with a pharmacist or the Health Canada Drug Product Database

Quick Do / Don't Checklist And Practical Tips

• Do read the label and confirm the active ingredient is mebeverine (Colofac) before buying.
• Do check with your pharmacist for a Drug Identification Number (DIN) or Health Canada status prior to purchase.
• Do ask a pharmacist about generics or equivalent antispasmodics if Colofac is not stocked locally.
• Don't use mebeverine for acute severe abdominal pain until a clinician rules out structural causes.
• Don't continue the medicine if you develop high fever, persistent vomiting, bloody stools or signs of allergic reaction — seek urgent care.
• Do carry blister packs when commuting and keep medication in original packaging when crossing provincial or international borders.
• Do store below 25°C (77°F) away from moisture and light, in the original blister packaging.
• Rural patients: phone ahead to local Shoppers Drug Mart, London Drugs or your community pharmacy to confirm stock or mail‑order options.
• Urban patients: compare prices and same‑day pickup availability at nearby pharmacies.

Pack	Strength	Typical Adult Dosing
Standard Tablets (example packaging)	135 mg	1 tablet three times daily
Prolonged‑Release Capsules	200 mg	1 capsule twice daily
Blister Packs (Australia/NZ example)	135 mg tablets (packs of 30 or 500)	As per tablet or capsule dosing above

Everyday Use & Best Practices

Morning Vs Evening Dosing In Canadian Routines

Many patients ask whether to take colofac in the morning or evening.

Standard adult dosing is either a 135 mg tablet three times daily or a 200 mg modified‑release capsule twice daily.

For three‑times‑daily schedules, taking the morning dose with breakfast, the midday dose at lunch and the evening dose with dinner fits most Canadian work and school routines.

For 200 mg MR capsules take doses roughly 12 hours apart, for example at 7 a.m. and 7 p.m.

Shift workers should set alarms or use pharmacy blister packs to avoid missed doses.

If you have an unpredictable schedule, ask your pharmacist for a dispensing pack that matches your shift pattern.

Taking With Or Without Meals (Canadian Diet Context)

Mebeverine can be taken with or without food according to product information.

If you experience reflux or heartburn, taking colofac with food may reduce stomach upset.

Canada’s varied diets include high‑fibre meals and occasional spicy foods, so track which meals trigger symptoms and time doses accordingly.

If a spicy or heavy meal reliably brings cramps, try taking the medication before or after that meal depending on whether it helps your symptoms.

Practical tips: set phone reminders, use blister packs for shift work and keep the original packaging when carrying medication in a purse or gym bag.

Safety Priorities

Who Should Avoid It (Health Canada Advisories)

A critical safety question is who must avoid mebeverine.

Mebeverine is contraindicated in people with known hypersensitivity to mebeverine or any excipients.

Do not use if you have a known paralytic ileus.

Certain formulations are contraindicated in hereditary galactose intolerance, Lapp lactase deficiency or glucose‑galactose malabsorption — check excipient lists.

Pregnant or breastfeeding people should discuss risks with their clinician and use mebeverine only if clearly needed.

Use with caution in severe liver or kidney impairment because clinical data are limited.

Confirm local advice with your pharmacist and check DIN / Health Canada resources if Colofac is not marketed under that brand locally.

Activities To Limit (Driving, Workplace Safety)

Mebeverine may rarely cause dizziness, headache or tiredness.

If you experience dizziness or fatigue after a dose, avoid driving or operating heavy machinery until you know how you respond.

Night‑shift workers should monitor alertness after initial doses before returning to safety‑sensitive duties.

Inform occupational health or your employer if you operate heavy equipment and are starting a new medication.

Students should plan dosing around exam schedules if side effects occur during the first days of therapy.

Dosage & Adjustments

General Regimen (DIN References)

Adult dosing for irritable bowel syndrome and non‑specific gut spasm follows standard regimens.

The usual regimens are 135 mg tablet three times daily or 200 mg prolonged‑release capsule twice daily.

In Canada, verify a product’s DIN and local product labelling with your pharmacist before starting treatment.

If no DIN is present, pharmacists can advise on legally permitted supply such as imported generics or alternative antispasmodics.

Special Cases (Elderly, Comorbidities)

No routine dose adjustment is usually necessary for elderly patients, but start standard dosing and monitor for dizziness or constipation.

For renal or hepatic impairment use mebeverine with caution and consult the prescriber for monitoring plans because data are limited.

Not recommended for children under 10 years as safety and efficacy are not established in pediatric populations.

For cardiac disease or severe liver disease, discuss risks and benefits with your clinician and review other medications for interactions or additive effects.

Population	Typical Dose	Notes / Alternatives
Adults	135 mg TID or 200 mg MR BID	Verify DIN and local labelling with pharmacist
Elderly	Standard adult dose	Monitor for dizziness; adjust if necessary
Children <10 years	Not recommended	Safety not established

User Testimonials

Positive Reports From Canadian Patients

Many patients report reduced cramping and quicker return to normal activities after starting mebeverine.

Users often note that colofac causes fewer anticholinergic side effects compared to older antispasmodics.

Urban patients appreciate pharmacy pickup convenience, while rural users value reliable mail‑order supplies.

Some patients comment that combining mebeverine with dietary measures improved outcomes.

Common Challenges In Forums

Forum threads on Reddit Canada and provincial health boards show variable individual response to mebeverine.

Initial mild side effects such as dizziness or headache appear in some reports but are generally uncommon.

Availability can be an issue, with pharmacists sometimes recommending equivalent antispasmodics if the Colofac brand is not stocked.

Cost and provincial coverage are recurring concerns — some people pay out of pocket when mebeverine is not on a provincial formulary.

Practical peer advice: keep a symptom diary for two to four weeks and consult your clinician if improvement is insufficient.

Buying Guide

Pharmacy Sources

Check major chains such as Shoppers Drug Mart, Rexall, Jean Coutu and London Drugs as a first step when seeking colofac or mebeverine equivalents.

If the Colofac brand is not stocked, ask the pharmacist about generics, therapeutic alternatives or legal importation routes.

Request bilingual labelling when available, especially if you need French packaging in Quebec.

Price Comparison (In‑Store Vs Online, Cross‑Border Notes)

Prices vary between in‑store, Canadian e‑pharmacies and manufacturer promotions, so compare unit price per tablet or capsule.

Provincial drug plans such as Ontario Drug Benefit, BC PharmaCare or RAMQ may not list mebeverine — confirm coverage before purchase.

Some Canadians consider U.S. online suppliers, but be cautious about customs, legal status and loss of Canadian consumer protections.

In our online pharmacy, colofac is available without a prescription, with discreet delivery to Canada (English) in 5-14 days.

Source	Pros	Cons
Local Chain Pharmacy	Immediate pickup, pharmacist consultation	May not stock the Colofac brand
Canadian E‑Pharmacy	Often lower price, delivery options	Delivery wait; check DIN and labelling
Cross‑Border Suppliers	Possible access to brand products	Customs, legality, limited recourse

What’s Inside & How It Works

Ingredients Overview

The active ingredient is mebeverine (INN).

Excipients vary by manufacturer and formulation, so check the printed ingredient list for allergies or dietary restrictions.

Certain formulations may contain lactose or other sugars and are contraindicated in hereditary galactose intolerance or glucose‑galactose malabsorption.

If you need an exact ingredient list, ask the pharmacist to print or email it or request bilingual labelling where required.

Mechanism Basics

Mebeverine is classified under ATC code A03AA04 for functional gastrointestinal disorders.

The drug is an antispasmodic that acts on gut smooth muscle to relieve spasm and pain without prominent systemic anticholinergic effects.

This profile makes colofac a reasonable option for patients sensitive to anticholinergic side effects.

Component	Note
Active Ingredient	Mebeverine
Formulations	135 mg tablets, 200 mg MR capsules, oral liquid equivalents
Warnings	Check excipients for hereditary carbohydrate disorders

Main Indications

Approved Uses In Canada

Internationally, mebeverine is used for relief of abdominal pain, cramps and bowel irregularity in irritable bowel syndrome.

Standard regimens are 135 mg TID or 200 mg MR BID for adults.

Confirm Health Canada approval and provincial formulary listings with a pharmacist if you are sourcing colofac within Canada.

Off‑Label Uses By Canadian Physicians

Some clinicians use mebeverine for other non‑specific GI spasm or functional bowel complaints where an antispasmodic might help.

Off‑label prescribing should include informed consent and an agreed monitoring plan.

Treatment duration varies; reassess if there is no meaningful improvement after approximately two weeks and consider diet, fibre, low FODMAP or alternative therapies.

Indication	Evidence Strength
IBS Abdominal Pain & Cramps	Moderate; shown to help some patients
Functional Gut Spasm	Used clinically; clinician judgement advised

Interaction Warnings

Food Interactions (Alcohol, Caffeine)

No major food interactions are documented in the product information.

Alcohol may increase dizziness or worsen GI symptoms, so monitor tolerance if drinking while taking colofac.

Caffeine and other stimulants can aggravate gut spasms in some people — consider symptom tracking if you suspect a link.

Drug Conflicts (Health Canada Database)

Mebeverine has no major interaction profile with most drugs according to available data.

Rarely, false positive urine drug screens for amphetamines have been reported.

Always provide a full medication list to your pharmacist and request a medication review if taking multiple therapies or herbal products.

Use provincial e‑health medication review services or Health Canada resources when in doubt.

Latest Evidence & Insights

Highlight Canadian And International Research

International studies and reviews report variable benefit for mebeverine in IBS symptom relief, with modest effects for some patients.

Mebeverine is favoured for a lower systemic anticholinergic profile compared with agents such as dicycloverine or hyoscine.

Canadian‑specific randomized controlled trial data are limited, so clinicians commonly rely on international evidence and local practice patterns.

Practical Takeaways For Patients

Expect symptom monitoring over two to eight weeks to judge benefit.

If improvement is partial, combine therapy with dietary measures such as a low FODMAP trial or increased soluble fibre, and consider psychological therapies where indicated.

Request copies of evidence summaries from your clinician to support shared decision‑making.

Study Type	Population	Outcome
International RCTs / Reviews	Adults with IBS	Variable benefit; some patients report meaningful symptom relief

Alternative Choices

Comparable Medicines With Pros/Cons Checklist

Other antispasmodics include dicycloverine (dicyclomine/Bentyl), hyoscine butylbromide (Buscopan), peppermint oil (Colpermin) and alverine citrate (Spasmonal).

Dicycloverine can be effective but carries more antimuscarinic side effects such as dry mouth and blurred vision.

Hyoscine butylbromide is useful for acute cramping but may not be suitable for long‑term management in sensitive patients.

Peppermint oil has evidence for IBS symptom relief and is a non‑prescription option for some patients.

Non‑Drug Options To Try First Or Alongside

Dietary changes like a low FODMAP plan, increased soluble fibre, regular exercise and gut‑directed psychological therapies (CBT or hypnotherapy) are key non‑drug approaches.

Combining mebeverine with diet and lifestyle changes often improves overall outcomes compared with medication alone.

Option	Pros	Cons
Dicycloverine	Effective for some patients	More anticholinergic side effects
Peppermint Oil	OTC, evidence for IBS	May cause heartburn in some
Diet / CBT	Addresses root triggers	Requires time and access to specialists

Regulation Snapshot

Health Canada Approval And DIN Requirements

Before purchasing in Canada, verify Health Canada approval and the product’s DIN with a pharmacist or the Health Canada Drug Product Database.

If a branded Colofac product is not listed locally, pharmacists can advise on legal access or suggest suitable alternatives.

Provincial Coverage Notes

Coverage varies by province and by plan; many provincial formularies may not list mebeverine by brand or generic.

Check Ontario Drug Benefit, BC PharmaCare or RAMQ formularies for listed alternatives or reimbursement rules before paying out of pocket.

Pharmacies can often submit prior‑authorization requests or suggest covered substitutes when appropriate.

Action	Steps
DIN Check	Ask pharmacist to confirm DIN and provide written confirmation
Provincial Formularies	Check ODB, BC PharmaCare, RAMQ and private insurer terms

Frequently Asked Questions

Is Colofac Available In Canada?

Mebeverine (Colofac) may not be widely marketed under that brand across Canada.

Confirm availability with your pharmacist and ask for DIN information or an equivalent antispasmodic if Colofac is not stocked.

How Long Until I Feel Better?

Many patients track two to eight weeks to assess meaningful symptom change.

If there is no improvement after a couple of weeks, contact your prescriber for review and possible alternative strategies.

Can I Take It While Breastfeeding?

Data are limited and use during breastfeeding is generally advised only if clinically necessary after a risk–benefit discussion with your prescriber.

Will Provincial Plans Cover It?

Coverage varies by province and by plan; check Ontario Drug Benefit, BC PharmaCare or RAMQ and ask your pharmacist about covered alternatives or reimbursement options.

• Bring these questions to the pharmacy: “Is the active ingredient mebeverine?”, “What is the DIN?”, “Is there a covered alternative on my formulary?”

Guidelines For Proper Use

Canadian Pharmacist And Provincial Health Authority Recommendations

Ask the pharmacist to confirm active ingredient, provide bilingual labelling if needed and verify the DIN before purchase.

Pharmacists can perform a medication review, check for rare urine‑screen interferences and provide written instructions for missed doses and storage.

Monitoring, Follow‑Up, And When To Stop

Keep a symptom diary and review effectiveness after two to four weeks with your prescriber or pharmacist.

Stop and seek urgent care for allergic reactions or signs suggesting severe abdominal pathology such as high fever, persistent vomiting or bloody stools.

Discontinue if there is no meaningful improvement after an agreed trial period or if intolerable side effects develop.

• Monitoring checklist: symptom diary, side effects log (dizziness, rash, GI changes), medication review with pharmacist at 2–4 weeks.

Delivery Across Canada (English)

City	Region	Delivery Time
Toronto	Ontario	5-7 days
Montreal	Quebec	5-7 days
Vancouver	British Columbia	5-7 days
Calgary	Alberta	5-7 days
Edmonton	Alberta	5-7 days
Ottawa	Ontario	5-7 days
Winnipeg	Manitoba	5-7 days
Quebec City	Quebec	5-9 days
Halifax	Nova Scotia	5-9 days
Saskatoon	Saskatchewan	5-9 days
Regina	Saskatchewan	5-9 days
Victoria	British Columbia	5-9 days
Hamilton	Ontario	5-7 days
Kitchener	Ontario	5-7 days
London	Ontario	5-9 days